U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935109) titled 'Management of Severe Plasmodium Falciparum Malaria With Oral Artemisinin Derivatives' on Oct. 07.
Brief Summary: ACTs could be used as first-line treatment for Plasmodium falciparum malaria without clinical signs of severity but with biological severity criteria.
The study aims to determine the real-world frequency of ACT monotherapy use in cases of P. falciparum malaria with severity criteria, and to compare the treatment success of ACTs with that of artesunate.
Study Start Date: July 15
Study Type: OBSERVATIONAL
Condition:
Malaria, Falciparum
Plasmodium Falciparum
Artemisinins
Antimalarials
Artesunate
Treatment Outcome
Recru...